Acer Therapeutics Inc
ACER
ACER was delisted on the 8th of November, 2023.
11 hedge funds and large institutions have $1.86M invested in Acer Therapeutics Inc in 2016 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 6 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
95% more capital invested
Capital invested by funds: $954K → $1.86M (+$903K)
21% less funds holding
Funds holding: 14 → 11 (-3)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$59.7K |
| 2 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
+$26.3K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$24.7K |
| 4 |
JWA
JFS Wealth Advisors
Hermitage,
Pennsylvania
|
+$714 |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$387 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EGA
Eagle Global Advisors
Houston,
Texas
|
-$65K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$12K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$6K |
| 4 |
Citigroup
New York
|
-$1K |
| 5 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
-$1K |
ACER Hedge Fund Activity: Q2 2016 in Review
11 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q2 2016, worth a combined $1.86M — up 95% from $954K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of ACER and 3 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 3 added.
The largest buyer was Renaissance Technologies, adding an estimated $59.7K. The largest seller was Eagle Global Advisors, exiting entirely with an estimated $65K sold.
- 11 institutional investors held Acer Therapeutics Inc (ACER) as of Q2 2016, down from 14 in Q1 2016.
- Funds reported $1.86M of Acer Therapeutics Inc stock for Q2 2016, up 95% quarter-over-quarter.
- 3 funds opened new Acer Therapeutics Inc positions in Q2 2016 and 6 closed out, a net change of -3 holders.
- The largest Acer Therapeutics Inc buyer in Q2 2016 was Renaissance Technologies, an estimated $59.7K added.
- The largest Acer Therapeutics Inc seller in Q2 2016 was Eagle Global Advisors, an estimated $65K sold.
Based on aggregated 13F filings for Q2 2016.